Michael R. Ward

Real-World Effectiveness of Mavacamten in Canada: Insights from the MAVEN Study

Previous studies have demonstrated the efficacy and safety of mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), primarily outside of Canada, with limited Canadian real-world data evidence. The MAVEN study aimed to describe the real-world effe...